SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $172M invested in SPDR S&P Pharmaceuticals ETF in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 14 closing their positions.
Holders
79
Holders Change
+1
Holders Change %
+1.28%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
19
Reduced
26
Closed
14
Calls
$852K
Puts
$7K
Net Calls
+$845K
Net Calls Change
+$1.53M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$25.8M |
| 2 |
2
Goldman Sachs
New York
|
$32.9M |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$5.24M |
| 4 |
4
BNP Paribas Financial Markets
Paris,
France
|
$4.18M |
| 5 |
5
Citigroup
New York
|
$5.31M |
